Posted: May 19th, 2022
Bristol-Myers Squibb Holdings Ireland Unlimited Company v. Sandoz B.V., District Court The Hague (interlocutory decision), 10 May 2022, Case no. ECLI:NL:RBDHA:2022:4385 BMS markets the medicine Eliquis®, with apixaban as the active ingredient. Apixaban is a substance that inhibits the action of factor Xa. Inhibiting factor Xa helps prevent blood clots from forming. Eliquis® is used […]
READ MORE
Posted: May 5th, 2022
Novartis Pharma vs. Medac Farma, Court of Milan, 10 January 2022, Case number 11933/2022 A decision on second medical use patent and skinny labelling in Italy was handed down by the Court of Milan on 10 January 2022. The Court held skinny label alone as insufficient to avoid infringement of second medical use claims and […]
READ MORE
Posted: April 29th, 2022
Preliminary ruling under Article 267 TFEU in the case between Phoenix Contact GmbH & Co. KG v. HARTING Deutschland GmbH & Co. KG, Harting Electric GmbH & Co. KG, 28 April 2022, Case No. C‑44/21, ECLI:EU:C:2022:309 “By its question, the referring court asks, in essence, whether Article 9(1) of Directive 2004/48 must be interpreted as […]
READ MORE
Posted: April 20th, 2022
Novartis versus Mylan, PI judge District Court of The Hague 22 March 2022, ECLI:NL:RBDHA:2022:2490 (interlocutory decision) Market entry by the generic pharmaceutical company Mylan before the grant of a Novartis patent – which will be infringed once granted – is not unlawful. Not even if Novartis’ patent will be granted with certainty and the wording […]
READ MORE
Posted: April 13th, 2022
Shark Helmets S.A.S. v. Tech Design Team S.L., Commercial Court no. 5 of Barcelona, 28 October 2021, Docket No. 729/2020 In this decision issued on 28 October 2021, Barcelona first instance Patent Courts examined the question of interpreting the extent of protection of the claims in view of the patent description and drawings. The plaintiff, […]
READ MORE
Posted: March 30th, 2022
Judgment handed down in the last of the technical trials in Optis v Apple saga: Optis succeeds in arguing that its patents are valid and infringed by Apple Overview The 15 March 2022 judgment of Mr Justice Meade is the latest in the Optis v Apple saga. It is the last in the series of […]
READ MORE
Posted: March 29th, 2022
Vorwerk v. Lidl Supermercados, Court of Appeals of Barcelona, Spain, 13 January 2022, Appeal Docket No. 880/2021 (ECLI:ES:APB:2022:1) One year after the first-instance ruling in one of the most mediatic patent cases in Spain, the Court of Appeals of Barcelona rendered a judgment changing course, namely inreversing the first instance judgment and declaring the invalidity […]
READ MORE
Posted: March 17th, 2022
Jones v. Irmac Roads Ltd [2022] EWHC 495 (IPEC) In these proceedings Jones sought a declaration (under s.37 of the Patents Act 1977; the “Patents Act”) that he, not Irmac Roads Ltd, was the proprietor of UK Patent No. 2 506 097 (“the Patent”) granted on 13 September 2017. The Patent claims an invention entitled […]
READ MORE
Posted: March 16th, 2022
Friedrich Ossenberg – Schule GmbH & Co. KG v. Roof & Tool Products B.V. and ESC Dronten B.V., District Court The Hague, The Netherlands, 2 March 2022, Case no. ECLI:NL:RBDHA:2022:1737 Ossenberg holds NL 1024003 related to a roof tile hook. Interpretation of claims. Patent is new and inventive. Roof tile hook defendant infringes patent. A […]
READ MORE
Posted: March 8th, 2022
Wiko SAS v. Koninklijke Philips N.V., Dutch Supreme Court, 25 February 2022, Case nos. ECLI:NL:HR:2022:296 and ECLI:NL:HR:2022:294 Standard Essential Patent (SEP) in Mobile Telecommunications. Infringement. Abuse of a dominant position? Is the license offer fair, reasonable and non-discriminatory (FRAND)? The Supreme Court confirms this judgment and this judgment of the Court of Appeal and dismisses the appeal without […]
READ MORE
EMAIL US
